Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results

Date
2019
Author
Zur, Dinah
Degenhardtu, Valentin
Unterlauft, Jan-Darius
Cagini, Carlo
Mane-Tauty, Valerie
Ricci, Giuseppe D'Amico
Hindi, Isaac
Agrawal, Kushal
Chhablani, Jay
Loewenstein, Anat
Rehak, Matus
Cebeci, Zafer
Busch, Catharina
Fraser-Bell, Samantha
Iglicki, Matias
Lupidi, Marco
Couturier, Aude
Chaikitmongkol, Voraporn
Giancipoli, Ermete
Rodriguez-Valdes, Patricio J.
Gabrielle, Pierre-Henry
Lains, Ines
Santos, Ana Rita
Phornphruet, Atchara Am
Metadata
Show full item record
Abstract
AimsTo provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under continued anti-VEGF therapy versus dexamethasone (DEX) implant.
URI
http://hdl.handle.net/20.500.12627/141759
https://doi.org/10.1007/s00592-019-01416-4
Collections